| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |